-
Product Insights
NewAirway Management Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Airway management refers to medical procedures performed for the prevention or alleviation of any obstruction in the airway. Airway management procedures are performed to open a pathway for maintaining or re-storing proper gas exchange between a patient's lungs and the atmosphere. This is accomplished with the use of infraglottic device (Endotracheal tubes) or supraglottic device (Laryngeal mask) or surgical method (Tracheostomy). The devices used for airway management are referred as airway management devices. GlobalData's Medical Devices sector report, “Airway Management...
-
Product Insights
Charcot-Marie-Tooth Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Charcot-Marie-Tooth Disease Type I A – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type I A - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease Type I A pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type I A, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Charcot-Marie-Tooth Disease Type I – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type I - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease Type I pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type I, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Retinitis Pigmentosa (Retinitis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Drugs In Development, 2023’, provides an overview of the Retinitis Pigmentosa (Retinitis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinitis Pigmentosa (Retinitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Retinopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Retinopathy - Drugs In Development, 2023’, provides an overview of the Retinopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Interstitial Lung Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Interstitial Lung Fibrosis - Drugs In Development, 2023’, provides an overview of the Interstitial Lung Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Marker Tests Pipeline Market Report Overview A cardiac marker test is a biomarker test used to diagnose cardiac diseases. The Cardiac Marker Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Other Cardiac...
-
Thematic Analysis
Artificial Intelligence (AI) in Clinical Practice – Patient Perspective – Thematic Intelligence
Artificial Intelligence (AI) in Clinical Practice Thematic Report Overview According to the survey, younger patients (18-55 years old) are more likely to be familiar with AI than the older (56+ years) patients as they have been exposed to technologies such as computers and smart devices from a younger age and thus, may be more comfortable with innovation use. Following this trend, patients familiar with AI selected more advantages associated with AI implementation in clinical practice compared to those unfamiliar with this technology. This...